Multiple roles of COUP-TFII in cancer initiation and progression

Journal of Molecular Endocrinology

Volumn 49, Issue 3, 2012, Pages

  Litchfield, Lacey M ^a   Klinge, Carolyn M ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 1; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; ESTROGEN RECEPTOR ALPHA; MICRORNA; RALOXIFENE; RETINOIC ACID; TAMOXIFEN;

BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CHEMOSENSITIVITY; DNA METHYLATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HORMONE SENSITIVITY; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STEROIDOGENESIS; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; TUMOR VASCULARIZATION;

ANIMALS; COUP TRANSCRIPTION FACTOR II; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION;

EID: 84867903031     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-12-0144     Document Type: Review

References (127)

1. Achen MG, McColl BK & Stacker SA 2005 Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 7 121-127. (doi:10.1016/ j.ccr.2005.01.017)
2. Aerbajinai W, Zhu J, Kumkhaek C, Chin K & Rodgers GP 2009 SCF induces gamma-globin gene expression by regulating downstream transcription factor COUP-TFII. Blood 114 187-194. (doi:10.1182/ blood-2008-07-170712)
3. Ahmad N & Kumar R 2011 Steroid hormone receptors in cancer development: a target for cancer therapeutics. Cancer Letters 300 1-9. (doi:10.1016/j.canlet.2010.09.008)
4. Annecke K, Schmitt M, Euler U, Zerm M, Paepke D, Paepke S, von Minckwitz G, Thomssen C & Harbeck N 2008 uPA and PAI-1 in breast cancer: review of their clinical utility and current validation in the prospective NNBC-3 trial. Advances in Clinical Chemistry 45 31-45. (doi:10.1016/S0065-2423(07)00002-9)
5. Bailey PJ, Dowhan DH, Franke K, Burke LJ, Downes M & Muscat GE 1997 Transcriptional repression by COUP-TF II is dependent on the C-terminal domain and involves the N-CoR variant, RIP13delta1. Journal of Steroid Biochemistry and Molecular Biology 63 165-174. (doi:10.1016/S0960-0760(97)00079-4)
6. Bakke M & Lund J 1995 Mutually exclusive interactions of two nuclear orphan receptors determine activity of a cyclic adenosine 30,50-monophosphate-responsive sequence in the bovine CYP17 gene. Molecular Endocrinology 9 327-339. (doi:10.1210/me.9.3.327)
7. Bardoux P, Zhang P, Flamez D, Perilhou A, Lavin TA, Tanti JF, Hellemans K, Gomas E, Godard C, Andreelli F et al. 2005 Essential role of chicken ovalbumin upstream promoter-transcription factor II in insulin secretion and insulin sensitivity revealed by conditional gene knockout. Diabetes 54 1357-1363. (doi:10.2337/ diabetes.54.5.1357)
8. Bell A, Bell D, Weber RS & El-Naggar AK 2011 CpG island methylation profiling in human salivary gland adenoid cystic carcinoma. Cancer 117 2898-2909. (doi:10.1002/cncr.25818)
9. Ben-Shushan E, Sharir H, Pikarsky E & Bergman Y 1995 A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells. Molecular and Cellular Biology 15 1034-1048.
10. Boutant M, Ramos OH, Tourrel-Cuzin C, Movassat J, Ilias A, Vallois D, Planchais J, Pegorier JP, Schuit F, Petit PX et al. 2012 COUP-TFII controls mouse pancreatic b-cell mass through GLP-1-b-catenin signaling pathways. PLoS ONE 7 e30847. (doi:10.1371/journal. pone.0030847)
11. Buholzer CF, Arrighi JF, Abraham S, Piguet V, Capponi AM & Casal AJ 2005 Chicken ovalbumin upstream promoter-transcription factor is a negative regulator of steroidogenesis in bovine adrenal glomerulosa cells. Molecular Endocrinology 19 65-75. (doi:10.1210/ me.2004-0061)
12. Bullinger L, Ehrich M, Dohner K, Schlenk RF, Dohner H, Nelson MR & van den Boom D 2010 Quantitative DNA methylation predicts survival in adult acute myeloid leukemia. Blood 115 636-642. (doi:10.1182/blood-2009-03-211003)
13. Bulun SE, Chen D, Moy I, Brooks DC & Zhao H 2012 Aromatase, breast cancer and obesity: a complex interaction. Trends in Endocrinology and Metabolism 23 83-89. (doi:10.1016/ j.tem.2011.10.003)
14. Calonge MJ, Seoane J & Massague J 2004 Opposite Smad and chicken ovalbumin upstream promoter transcription factor inputs in the regulation of the collagen VII gene promoter by transforming growth factor-b. Journal of Biological Chemistry 279 23759-23765. (doi:10.1074/jbc.M402178200)
15. Chen S, Ye J, Kijima I, Kinoshita Y & Zhou D 2005 Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue. Journal of Steroid Biochemistry and Molecular Biology 95 17-23. (doi:10.1016/j.jsbmb.2005.04.002)
16. Chu K & Zingg HH 1997 The nuclear orphan receptors COUP-TFII and Ear-2 act as silencers of the human oxytocin gene promoter. Journal of Molecular Endocrinology 19 163-172. (doi:10.1677/jme.0. 0190163)
17. Cooney AJ, Leng X, Tsai SY, O'Malley BW & Tsai MJ 1993 Multiple mechanisms of chicken ovalbumin upstream promoter transcription factor-dependent repression of transactivation by the vitamin D, thyroid hormone, and retinoic acid receptors. Journal of Biological Chemistry 268 4152-4160.
18. Deaton AM & Bird A 2011 CpG islands and the regulation of transcription. Genes and Development 25 1010-1022. (doi:10.1101/ gad.2037511)
19. De Martino MU, Alesci S, Chrousos GP & Kino T 2004a Interaction of the glucocorticoid receptor and the chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII): implications for the actions of glucocorticoids on glucose, lipoprotein, and xenobiotic metabolism. PNAS 1024 72-85. (doi:10.1196/annals.1321.006)
20. De Martino MU, Bhattachryya N, Alesci S, Ichijo T, Chrousos GP & Kino T 2004b The glucocorticoid receptor and the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II interact with and mutually affect each other's transcriptional activities: implications for intermediary metabolism. Molecular Endocrinology 18 820-833. (doi:10.1210/me.2003-0341)
21. van den Driesche S, Walker M, McKinnell C, Scott HM, Eddie SL, Mitchell RT, Seckl JR, Drake AJ, Smith LB, Anderson RA et al. 2012 Proposed role for COUP-TFII in regulating fetal leydig cell steroidogenesis, perturbation of which leads to masculinization disorders in rodents. PLoS ONE 7 e37064. (doi:10.1371/journal. pone.0037064)
22. Enjuanes A, Fernandez V, Hernandez L, Navarro A, Bea S, Pinyol M, Lopez-Guillermo A, Rosenwald A, Ott G, Campo E et al. 2011 Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma. PLoS ONE 6 e19736. (doi:10.1371/journal.pone.0019736)
23. Eubank DW, Duplus E, Williams SC, Forest C & Beale EG 2001 Peroxisome proliferator-activated receptor g and chicken ovalbumin upstream promoter transcription factor II negatively regulate the phosphoenolpyruvate carboxykinase promoter via a common element. Journal of Biological Chemistry 276 30561-30569. (doi:10.1074/jbc.M103019200)
24. Fan M, Yan PS, Hartman-Frey C, Chen L, Paik H, Oyer SL, Salisbury JD, Cheng AS, Li L, Abbosh PH et al. 2006 Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant. Cancer Research 66 11954-11966. (doi:10.1158/ 0008-5472.CAN-06-1666)
25. Ferguson R, Novosyadlyy R, Fierz Y, Alikhani N, Sun H, Yakar S & LeRoith D 2012 Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes. Breast Cancer Research 14 R8. (doi:10.1186/bcr3089)
26. Fernandez-Rachubinski F & Fliegel L 2001 COUP-TFI and COUP-TFII regulate expression of the NHE through a nuclear hormone responsive element with enhancer activity. European Journal of Biochemistry 268 620-634. (doi:10.1046/j.1432-1327.2001. 01915.x)
27. Francois M, Harvey NL & Hogan BM 2011 The transcriptional control of lymphatic vascular development. Physiology 26 146-155. (doi:10.1152/physiol.00053.2010)
28. Garcia A & Kandel JJ 2012 Notch: a key regulator of tumor angiogenesis and metastasis. Histology and Histopathology 27 151-156.
29. Gu JW, Rizzo P, Pannuti A, Golde T, Osborne B & Miele L 2012 Notch signals in the endothelium and cancer "stem-like" cells: opportunities for cancer therapy. Vascular Cell 4 7. (doi:10.1186/ 2045-824X-4-7)
30. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL et al. 2009 Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. Journal of the National Cancer Institute 101 48-60. (doi:10.1093/jnci/djn415)
31. Hammond GL 2011 Diverse roles for sex hormone-binding globulin in reproduction. Biology of Reproduction 85 431-441. (doi:10.1095/ biolreprod.111.092593)
32. Hanahan D & Weinberg RA 2011 Hallmarks of cancer: the next generation. Cell 144 646-674. (doi:10.1016/j.cell.2011.02.013)
33. Harbeck N, Kates RE, Schmitt M, Gauger K, Kiechle M, Janicke F, Thomassen C, Look MP & Foekens JA 2004 Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer. Clinical Breast Cancer 5 348-352. (doi:10.3816/CBC.2004.n.040)
34. Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, Brennan KR, Bundred NJ & Clarke RB 2010 Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Research 70 709-718. (doi:10.1158/0008-5472.CAN-09-1681)
35. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT & De Bruijn EA 2004 Vascular endothelial growth factor and angiogenesis. Pharmacological Reviews 56 549-580. (doi:10.1124/ pr.56.4.3)
36. Holbeck S, Chang J, Best AM, Bookout AL, Mangelsdorf DJ & Martinez ED 2010 Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions. Molecular Endocrinology 24 1287-1296. (doi:10.1210/ me.2010-0040)
37. Huggins GS, Bacani CJ, Boltax J, Aikawa R & Leiden JM 2001 Friend of GATA 2 physically interacts with chicken ovalbumin upstream promoter-TF2 (COUP-TF2) and COUP-TF3 and represses COUPTF2-dependent activation of the atrial natriuretic factor promoter. Journal of Biological Chemistry 276 28029-28036. (doi:10.1074/ jbc.M103577200)
38. Incassati A, Chandramouli A, Eelkema R & Cowin P 2010 Key signaling nodes in mammary gland development and cancer: b-catenin. Breast Cancer Research 12 213. (doi:10.1186/bcr2723)
39. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M et al. 2009 The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specific CpG island shores. Nature Genetics 41 178-186. (doi:10.1038/ng.298)
40. Janne M & Hammond GL 1998 Hepatocyte nuclear factor-4 controls transcription from a TATA-less human sex hormone-binding globulin gene promoter. Journal of Biological Chemistry 273 34105-34114. (doi:10.1074/jbc.273.51.34105)
41. Jiang G, Nepomuceno L, Hopkins K & Sladek FM 1995 Exclusive homodimerization of the orphan receptor hepatocyte nuclear factor 4 defines a new subclass of nuclear receptors. Molecular and Cellular Biology 15 5131-5143.
42. Jordan VC 2009 A century of deciphering the control mechanisms of sex steroid action in breast and prostate cancer: the origins of targeted therapy and chemoprevention. Cancer Research 69 1243-1254. (doi:10.1158/0008-5472.CAN-09-0029)
43. Kang J, Yoo J, Lee S, Tang W, Aguilar B, Ramu S, Choi I, Otu HH, Shin JW, Dotto GP et al. 2010 An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells. Blood 116 140-150. (doi:10.1182/blood-2009-11-252270)
44. Kliewer SA, Umesono K, Heyman RA, Mangelsdorf DJ, Dyck JA & Evans RM 1992 Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling. PNAS 89 1448-1452. (doi:10.1073/pnas.89.4.1448)
45. Klinge CM, Silver BF, Driscoll MD, Sathya G, Bambara RA & Hilf R 1997 Chicken ovalbumin upstream promoter-transcription factor interacts with estrogen receptor, binds to estrogen response elements and half-sites, and inhibits estrogen-induced gene expression. Journal of Biological Chemistry 272 31465-31474. (doi:10.1074/jbc.272.50.31465)
46. Krishnan V, Pereira FA, Qiu Y, Chen CH, Beachy PA, Tsai SY & Tsai MJ 1997 Mediation of Sonic hedgehog-induced expression of COUP-TFII by a protein phosphatase. Science 278 1947-1950. (doi:10.1126/science.278.5345.1947)
47. Kruse SW, Suino-Powell K, Zhou XE, Kretschman JE, Reynolds R, Vonrhein C, Xu Y, Wang L, Tsai SY, Tsai MJ et al. 2008 Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor. PLoS Biology 6 e227. (doi:10.1371/journal.pbio.0060227)
48. Ktistaki E & Talianidis I 1997 Chicken ovalbumin upstream promoter transcription factors act as auxiliary cofactors for hepatocyte nuclear factor 4 and enhance hepatic gene expression. Molecular and Cellular Biology 17 2790-2797.
49. Kurihara I, Shibata H, Kobayashi S, Suda N, Ikeda Y, Yokota K, Murai A, Saito I, Rainey WE & Saruta T 2005 Ubc9 and protein inhibitor of activated STAT 1 activate chicken ovalbumin upstream promotertranscription factor I-mediated human CYP11B2 gene transcription. Journal of Biological Chemistry 280 6721-6730. (doi:10.1074/jbc. M411820200)
50. Kyrmizi I, Hatzis P, Katrakili N, Tronche F, Gonzalez FJ & Talianidis I 2006 Plasticity and expanding complexity of the hepatic transcription factor network during liver development. Genes and Development 20 2293-2305. (doi:10.1101/gad.390906)
51. Lavrentiadou SN, Hadzopoulou-Cladaras M, Kardassis D & Zannis VI 1999 Binding specificity and modulation of the human ApoCIII promoter activity by heterodimers of ligand-dependent nuclear receptors. Biochemistry 38 964-975. (doi:10.1021/bi981068i)
52. Lee MO, Liu Y & Zhang XK 1995 A retinoic acid response element that overlaps an estrogen response element mediates multihormonal sensitivity in transcriptional activation of the lactoferrin gene. Molecular and Cellular Biology 15 4194-4207.
53. Lee CT, Li L, Takamoto N, Martin JF, Demayo FJ, Tsai MJ & Tsai SY 2004 The nuclear orphan receptor COUP-TFII is required for limb and skeletal muscle development. Molecular and Cellular Biology 24 10835-10843. (doi:10.1128/MCB.24.24.10835-10843.2004)
54. Lee KN, Jang WG, Kim EJ, Oh SH, Son HJ, Kim SH, Franceschi R, Zhang XK, Lee SE & Koh JT 2012 Orphan nuclear receptor COUPTFII negatively regulates BMP2-induced osteoblast differentiation through suppressing Runx2 activity. Journal of Biological Chemistry 287 18888-18899.
55. Leong KG, Niessen K, Kulic I, Raouf A, Eaves C, Pollet I & Karsan A 2007 Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. Journal of Experimental Medicine 204 2935-2948. (doi:10.1084/jem.20071082)
56. Li X, Misik AJ, Rieder CV, Solaro RJ, Lowen A & Fliegel L 2002 Thyroid hormone receptor a1 regulates expression of the NaC/HC exchanger (NHE1). Journal of Biological Chemistry 277 28656-28662. (doi:10.1074/jbc.M203221200)
57. Liberati C, Cera MR, Secco P, Santoro C, Mantovani R, Ottolenghi S & Ronchi A 2001 Cooperation and competition between the binding of COUP-TFII and NF-Y on human epsilon-and gamma-globin gene promoters. Journal of Biological Chemistry 276 41700-41709. (doi:10.1074/jbc.M102987200)
58. Lin B, Chen GQ, Xiao D, Kolluri SK, Cao X, Su H & Zhang XK 2000 Orphan receptor COUP-TF is required for induction of retinoic acid receptor b, growth inhibition, and apoptosis by retinoic acid in cancer cells. Molecular and Cellular Biology 20 957-970. (doi:10.1128/ MCB.20.3.957-970.2000)
59. Lin F, Kolluri SK, Chen GQ & Zhang XK 2002 Regulation of retinoic acid-induced inhibition of AP-1 activity by orphan receptor chicken ovalbumin upstream promoter-transcription factor. Journal of Biological Chemistry 277 21414-21422. (doi:10.1074/jbc.M201885200)
60. Lin FJ, Chen X, Qin J, Hong YK, Tsai MJ & Tsai SY 2010 Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development. Journal of Clinical Investigation 120 1694-1707. (doi:10.1172/JCI40101)
61. Lin FJ, Qin J, Tang K, Tsai SY & Tsai MJ 2011 Coup d'Etat: an orphan takes control. Endocrine Reviews 32 404-421.
62. Litchfield LM, Riggs KA, Hockenberry AM, Oliver LD, Barnhart KG, Cai J, Pierce WM Jr, Ivanova MM, Bates PJ, Appana SN et al. 2012 Identification and characterization of nucleolin as a COUP-TFII coactivator of retinoic acid receptor b transcription in breast cancer cells. PLoS ONE 7 e38278. (doi:10.1371/journal.pone.0038278)
63. Lovat F, Valeri N & Croce CM 2011 MicroRNAs in the pathogenesis of cancer. Seminars in Oncology 38 724-733. (doi:10.1053/j.seminoncol. 2011.08.006)
64. Ma X, Xu L, Wang S, Cui B, Li X, Xu J & Ning G 2011 Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis. Journal of Hepatology 55 445-452. (doi:10.1016/j.jhep.2010.11.022)
65. Magnifico A, Albano L, Campaner S, Delia D, Castiglioni F, Gasparini P, Sozzi G, Fontanella E, Menard S & Tagliabue E 2009 Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab. Clinical Cancer Research 15 2010-2021. (doi:10.1158/1078-0432.CCR-08-1327)
66. Marcus SL, Winrow CJ, Capone JP & Rachubinski RA 1996 A p56 (lck) ligand serves as a coactivator of an orphan nuclear hormone receptor. Journal of Biological Chemistry 271 27197-27200. (doi:10.1074/jbc.271.44.27197)
67. Marquez-Garban DC, Chen HW, Goodglick L, Fishbein MC & Pietras RJ 2009 Targeting aromatase and estrogen signaling in human non-small cell lung cancer. Annals of the New York Academy of Sciences 1155 194-205. (doi:10.1111/j.1749-6632.2009.04116.x)
68. Mietus-Snyder M, Sladek FM, Ginsburg GS, Kuo CF, Ladias JA, Darnell JE Jr & Karathanasis SK 1992 Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells. Molecular and Cellular Biology 12 1708-1718.
69. More E, Fellner T, Doppelmayr H, Hauser-Kronberger C, Dandachi N, Obrist P, Sandhofer F & Paulweber B 2003 Activation of the MAP kinase pathway induces chicken ovalbumin upstream promotertranscription factor II (COUP-TFII) expression in human breast cancer cell lines. Journal of Endocrinology 176 83-94. (doi:10.1677/ joe.0.1760083)
70. Nagasaki S, Suzuki T, Miki Y, Akahira J, Shibata H, Ishida T, Ohuchi N & Sasano H 2009 Chicken ovalbumin upstream promoter transcription factor II in human breast carcinoma: possible regulator of lymphangiogenesis via vascular endothelial growth factor-C expression. Cancer Science 100 639-645. (doi:10.1111/j. 1349-7006.2008.01078.x)
71. Nakshatri H & Chambon P 1994 The directly repeated RG(G/T)TCA motifs of the rat and mouse cellular retinol-binding protein II genes are promiscuous binding sites for RAR, RXR, HNF-4, and ARP-1 homo-and heterodimers. Journal of Biological Chemistry 269 890-902.
72. Nakshatri H, Mendonca MS, Bhat-Nakshatri P, Patel NM, Goulet RJ Jr & Cornetta K 2000 The orphan receptor COUP-TFII regulates G2/M progression of breast cancer cells by modulating the expression/activity of p21(WAF1/CIP1), cyclin D1, and cdk2. Biochemical and Biophysical Research Communications 270 1144-1153. (doi:10.1006/bbrc.2000.2562)
73. Navab R, Gonzalez-Santos JM, Johnston MR, Liu J, Brodt P, Tsao MS & Hu J 2004 Expression of chicken ovalbumin upstream promotertranscription factor II enhances invasiveness of human lung carcinoma cells. Cancer Research 64 5097-5105. (doi:10.1158/0008-5472.CAN-03-1185)
74. Ni YG, Wang N, CaoDJ, Sachan N, Morris DJ, Gerard RD, Kuro OM, Rothermel BA&Hill JA 2007 FoxO transcription factors activateAkt and attenuate insulin signaling in heart by inhibiting protein phosphatases. PNAS 104 20517-20522. (doi:10.1073/pnas.0610290104)
75. Ochoa A, Bovard-Houppermans S & Zakin MM 1993 Human apolipoprotein A-IV gene expression is modulated by members of the nuclear hormone receptor superfamily. Biochimica et Biophysica Acta 1210 41-47. (doi:10.1016/0005-2760(93)90047-D)
76. Okamura M, Kudo H, Wakabayashi K, Tanaka T, Nonaka A, Uchida A, Tsutsumi S, Sakakibara I, Naito M, Osborne TF et al. 2009 COUPTFII acts downstream of Wnt/b-catenin signal to silence PPARg gene expression and repress adipogenesis. PNAS 106 5819-5824. (doi:10.1073/pnas.0901676106)
77. Pannuti A, Foreman K, Rizzo P, Osipo C, Golde T, Osborne B & Miele L 2010 Targeting Notch to target cancer stem cells. Clinical Cancer Research 16 3141-3152. (doi:10.1158/1078-0432.CCR-09-2823)
78. Pereira FA, Qiu Y, Zhou G, Tsai MJ & Tsai SY 1999 The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes and Development 13 1037-1049. (doi:10.1101/ gad.13.8.1037)
79. Perilhou A, Tourrel-Cuzin C, Kharroubi I, Henique C, Fauveau V, Kitamura T, Magnan C, Postic C, Prip-Buus C & Vasseur-Cognet M 2008a The transcription factor COUP-TFII is negatively regulated by insulin and glucose via Foxo1-and ChREBP-controlled pathways. Molecular and Cellular Biology 28 6568-6579. (doi:10.1128/MCB. 02211-07)
80. Perilhou A, Tourrel-Cuzin C, Zhang P, Kharroubi I, Wang H, Fauveau V, Scott DK, Wollheim CB & Vasseur-Cognet M 2008b The MODY1 gene for hepatocyte nuclear factor 4a and a feedback loop control COUP-TFII expression in pancreatic b cells. Molecular and Cellular Biology 28 4588-4597. (doi:10.1128/MCB.01191-07)
81. Petit FG, Salas R, Tsai MJ & Tsai SY 2004 The regulation of COUP-TFII gene expression by Ets-1 is enhanced by the steroid receptor co-activators. Mechanisms of Ageing and Development 125 719-732. (doi:10.1016/j.mad.2004.03.009)
82. Pineda Torra I, Jamshidi Y, Flavell DM, Fruchart JC & Staels B 2002 Characterization of the human PPARa promoter: identification of a functional nuclear receptor response element. Molecular Endocrinology 16 1013-1028. (doi:10.1210/me.16.5.1013)
83. Pipaon C, Tsai SY & Tsai MJ 1999 COUP-TF upregulates NGFI-A gene expression through an Sp1 binding site. Molecular and Cellular Biology 19 2734-2745.
84. Power SC & Cereghini S 1996 Positive regulation of the vHNF1 promoter by the orphan receptors COUP-TF1/Ear3 and COUP-TFII/Arp1. Molecular and Cellular Biology 16 778-791.
85. Prahalad P, Dakshanamurthy S, Ressom H & Byers SW 2010 Retinoic acid mediates regulation of network formation by COUP-TFII and VE-cadherin expression by TGFb receptor kinase in breast cancer cells. PLoS ONE 5 e10023. (doi:10.1371/journal.pone.0010023)
86. Qin J, Chen X, Xie X, Tsai MJ & Tsai SY 2010a COUP-TFII regulates tumor growth and metastasis by modulating tumor angiogenesis. PNAS 107 3687-3692. (doi:10.1073/pnas.0914619107)
87. Qin J, Chen X, Yu-Lee LY, Tsai MJ & Tsai SY 2010b Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling. Cancer Research 70 8812-8821. (doi:10.1158/0008-5472.CAN-10-0551)
88. Riggs KA, Wickramasinghe NS, Cochrum RK, Watts MB & Klinge CM 2006 Decreased chicken ovalbumin upstream promoter transcription factor II expression in tamoxifen-resistant breast cancer cells. Cancer Research 66 10188-10198. (doi:10.1158/0008-5472.CAN-05-3937)
89. Risbridger GP, Davis ID, Birrell SN & Tilley WD 2010 Breast and prostate cancer: more similar than different. Nature Reviews. Cancer 10 205-212. (doi:10.1038/nrc2795)
90. Robinson CE, Wu X, Nawaz Z, Onate SA & Gimble JM 1999 A corepressor and chicken ovalbumin upstream promoter transcriptional factor proteins modulate peroxisome proliferator-activated receptor-g2/retinoid X receptor a-activated transcription from the murine lipoprotein lipase promoter. Endocrinology 140 1586-1593. (doi:10.1210/en.140.4.1586)
91. Rodriguez JC, Ortiz JA, Hegardt FG & Haro D 1997 Chicken ovalbumin upstream-promoter transcription factor (COUP-TF) could act as a transcriptional activator or repressor of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene. Biochemical Journal 326 587-592.
92. Rosa A & Brivanlou AH 2011 A regulatory circuitry comprised of miR-302 and the transcription factors OCT4 and NR2F2 regulates human embryonic stem cell differentiation. EMBO Journal 30 237-248. (doi:10.1038/emboj.2010.319)
93. Rufibach LE, Duncan SA, Battle M & Deeb SS 2006 Transcriptional regulation of the human hepatic lipase (LIPC) gene promoter. Journal of Lipid Research 47 1463-1477. (doi:10.1194/jlr.M600082-JLR200)
94. Sagami I, Tsai SY, Wang H, Tsai MJ & O'Malley BW 1986 Identification of two factors required for transcription of the ovalbumin gene. Molecular and Cellular Biology 6 4259-4267.
95. Sauvaget D, Chauffeton V, Citadelle D, Chatelet FP, Cywiner-Golenzer C, Chambaz J, Pincon-RaymondM, Cardot P, LeBeyec J&RibeiroA2002 Restriction of apolipoprotein A-IV gene expression to the intestine villus depends on a hormone-responsive element and parallels differential expressionof the hepaticnuclear factor 4a andgisoforms. Journal of Biological Chemistry 277 34540-34548. (doi:10.1074/ jbc.M206074200)
96. Selva DM, Hogeveen KN & Hammond GL 2005 Repression of the human sex hormone-binding globulin gene in Sertoli cells by upstream stimulatory transcription factors. Journal of Biological Chemistry 280 4462-4468. (doi:10.1074/jbc.M409616200)
97. Shenker N & Flanagan JM 2012 Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research. British Journal of Cancer 106 248-253. (doi:10.1038/ bjc.2011.550)
98. Shibata H, Nawaz Z, Tsai SY, O'Malley BW & Tsai MJ 1997 Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT). Molecular Endocrinology 11 714-724. (doi:10.1210/me.11.6.714)
99. Shibata H, Kobayashi S, Kurihara I, Suda N, Yokota K, Murai A, Ikeda Y, Saito I, Rainey WE & Saruta T 2004 COUP-TF and transcriptional co-regulators in adrenal steroidogenesis. Endocrine Research 30 795-801. (doi:10.1081/ERC-200044042)
100. Shimizu M, Cohen B, Goldvasser P, Berman H, Virtanen C & ReedijkM 2011 Plasminogen activator uPA is a direct transcriptional target of the JAG1-Notch receptor signaling pathway in breast cancer. Cancer Research 71 277-286. (doi:10.1158/0008-5472.CAN-10-2523)
101. Siddikuzzaman, Guruvayoorappan C & Berlin Grace VM 2011 All trans retinoic acid and cancer. Immunopharmacology and Immunotoxicology 33 241-249. (doi:10.3109/08923973.2010.521507)
102. Sikora MJ, Cordero KE, Larios JM, Johnson MD, Lippman ME & Rae JM 2009 The androgen metabolite 5a-androstane-3b,17b-diol (3badiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance. Breast Cancer Research and Treatment 115 289-296. (doi:10.1007/s10549-008-0080-8)
103. Sikora MJ, Strumba V, Lippman ME, Johnson MD & Rae JM 2012 Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation. Breast Cancer Research and Treatment 134 1027-1039.
104. Srinivasan RS, Geng X, Yang Y, Wang Y, Mukatira S, Studer M, Porto MP, Lagutin O & Oliver G 2010 The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes and Development 24 696-707. (doi:10.1101/gad.1859310)
105. Stanisic V, Lonard DM & O'Malley BW 2010 Modulation of steroid hormone receptor activity. Progress in Brain Research 181 153-176. (doi:10.1016/S0079-6123(08)81009-6)
106. Stroup D & Chiang JY 2000 HNF4 and COUP-TFII interact to modulate transcription of the cholesterol 7a-hydroxylase gene (CYP7A1). Journal of Lipid Research 41 1-11.
107. Stylianou S, Clarke RB & Brennan K 2006 Aberrant activation of Notch signaling in human breast cancer. Cancer Research 66 1517-1525. (doi:10.1158/0008-5472.CAN-05-3054)
108. Suzuki T, Moriya T, Darnel AD, Takeyama J & Sasano H 2000a Immunohistochemical distribution of chicken ovalbumin upstream promoter transcription factor II in human tissues. Molecular and Cellular Endocrinology 164 69-75. (doi:10.1016/S0303-7207(00)00242-2)
109. Suzuki T, Takahashi K, Darnel AD, Moriya T, Murakami O, Narasaka T, Takeyama J & Sasano H 2000b Chicken ovalbumin upstream promoter transcription factor II in the human adrenal cortex and its disorders. Journal of Clinical Endocrinology and Metabolism 85 2752-2757. (doi:10.1210/jc.85.8.2752)
110. Tang K, Xie X, Park JI, Jamrich M, Tsai S & Tsai MJ 2010 COUP-TFs regulate eye development by controlling factors essential for optic vesicle morphogenesis. Development 137 725-734. (doi:10.1242/dev. 040568)
111. Tanimoto K, Liu Q, Grosveld F, Bungert J & Engel JD 2000 Contextdependent EKLF responsiveness defines the developmental specificity of the human epsilon-globin gene in erythroid cells of YAC transgenic mice. Genes and Development 14 2778-2794. (doi:10.1101/gad.822500)
112. Thornton JW 2001 Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions. PNAS 98 5671-5676. (doi:10.1073/pnas.091553298)
113. Thornton JW, Need E & Crews D 2003 Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling. Science 301 1714-1717. (doi:10.1126/science.1086185)
114. Tobler NE & Detmar M 2006 Tumor and lymph node lymphangiogenesis-impact on cancer metastasis. Journal of Leukocyte Biology 80 691-696. (doi:10.1189/jlb.1105653)
115. Tommasi S, Karm DL, Wu X, Yen Y & Pfeifer GP 2009 Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer. Breast Cancer Research 11 R14. (doi:10.1186/bcr2233)
116. Tsai SY & Tsai M-J 1997 Chick ovalbumin upstream promotertranscription factors (COUP-TFs): coming of age. Endocrine Reviews 18 229-240. (doi:10.1210/er.18.2.229)
117. Vasyutina E & Birchmeier C 2006 The development of migrating muscle precursor cells. Anatomy and Embryology 211 (Suppl 1) 37-41. (doi:10.1007/s00429-006-0118-9)
118. Vincent A, Omura N, Hong SM, Jaffe A, Eshleman J & Goggins M 2011 Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma. Clinical Cancer Research 17 4341-4354. (doi:10.1158/1078-0432.CCR-10-3431)
119. Vittet D, Merdzhanova G, Prandini MH, Feige JJ & Bailly S 2012 TGFss1 inhibits lymphatic endothelial cell differentiation from mouse embryonic stem cells. Journal of Cellular Physiology 227 3593-3602.
120. Widom RL, Rhee M & Karathanasis SK 1992 Repression by ARP-1 sensitizes apolipoprotein AI gene responsiveness to RXRa and retinoic acid. Molecular and Cellular Biology 12 3380-3389.
121. Wu Q, Li Y, Liu R, Agadir A, Lee MO, Liu Y & Zhang X 1997 Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization. EMBO Journal 16 1656-1669. (doi:10.1093/emboj/16.7.1656)
122. Yang C, Yu B, Zhou D & Chen S 2002 Regulation of aromatase promoter activity in human breast tissue by nuclear receptors. Oncogene 21 2854-2863. (doi:10.1038/sj.onc.1205386)
123. You M, Fischer M, Cho WK & Crabb D 2002 Transcriptional control of the human aldehyde dehydrogenase 2 promoter by hepatocyte nuclear factor 4: inhibition by cyclic AMP and COUP transcription factors. Archives of Biochemistry and Biophysics 398 79-86. (doi:10.1006/abbi.2001.2713)
124. You LR, Lin FJ, Lee CT, DeMayo FJ, Tsai MJ & Tsai SY 2005 Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435 98-104. (doi:10.1038/nature03511)
125. Yu RN, Ito M & Jameson JL 1998 The murine Dax-1 promoter is stimulated by SF-1 (steroidogenic factor-1) and inhibited by COUPTF (chicken ovalbumin upstream promoter-transcription factor) via a composite nuclear receptor-regulatory element. Molecular Endocrinology 12 1010-1022. (doi:10.1210/me.12.7.1010)
126. Zeitoun K, Takayama K, Michael MD & Bulun SE 1999 Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. Molecular Endocrinology 13 239-253. (doi:10.1210/me.13.2.239)
127. Zhang LJ, Liu X, Gafken PR, Kioussi C & Leid M 2009 A chicken ovalbumin upstream promoter transcription factor I (COUP-TFI) complex represses expression of the gene encoding tumor necrosis factor a-induced protein 8 (TNFAIP8). Journal of Biological Chemistry 284 6156-6168. (doi:10.1074/jbc.M807713200)